Washington Trust Advisors Inc. Purchases 5,887 Shares of Intuitive Surgical, Inc. $ISRG

Washington Trust Advisors Inc. raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 35.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,718 shares of the medical equipment provider’s stock after buying an additional 5,887 shares during the period. Washington Trust Advisors Inc.’s holdings in Intuitive Surgical were worth $9,238,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. XXI Wealth LLC increased its holdings in Intuitive Surgical by 30.6% during the 3rd quarter. XXI Wealth LLC now owns 3,391 shares of the medical equipment provider’s stock worth $1,379,000 after purchasing an additional 795 shares during the last quarter. Yousif Capital Management LLC boosted its stake in shares of Intuitive Surgical by 1.0% during the 3rd quarter. Yousif Capital Management LLC now owns 46,382 shares of the medical equipment provider’s stock valued at $18,860,000 after buying an additional 458 shares during the last quarter. BIP Wealth LLC boosted its stake in shares of Intuitive Surgical by 4.7% during the 3rd quarter. BIP Wealth LLC now owns 826 shares of the medical equipment provider’s stock valued at $336,000 after buying an additional 37 shares during the last quarter. Boomfish Wealth Group LLC boosted its stake in shares of Intuitive Surgical by 112.9% during the 3rd quarter. Boomfish Wealth Group LLC now owns 5,469 shares of the medical equipment provider’s stock valued at $2,224,000 after buying an additional 2,900 shares during the last quarter. Finally, MBL Wealth LLC grew its position in shares of Intuitive Surgical by 91.7% during the third quarter. MBL Wealth LLC now owns 2,226 shares of the medical equipment provider’s stock worth $905,000 after buying an additional 1,065 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 1,089 shares of the firm’s stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $374.44, for a total transaction of $407,765.16. Following the completion of the transaction, the vice president directly owned 1,026 shares in the company, valued at $384,175.44. This represents a 51.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock valued at $4,891,989 over the last quarter. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research analyst reports. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. Wells Fargo & Company reiterated an “overweight” rating and set a $486.00 price objective (down from $487.00) on shares of Intuitive Surgical in a research note on Wednesday. TD Cowen reissued a “buy” rating and set a $485.00 price objective on shares of Intuitive Surgical in a report on Monday. UBS Group reissued a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 13th. Finally, Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $493.54.

Intuitive Surgical Stock Up 1.9%

Shares of NASDAQ:ISRG traded up $8.44 on Friday, reaching $452.29. 3,004,340 shares of the company’s stock were exchanged, compared to its average volume of 2,247,738. The firm has a market capitalization of $156.78 billion, a price-to-earnings ratio of 54.69, a PEG ratio of 3.31 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The business’s 50-day moving average is $395.50 and its two-hundred day moving average is $409.13.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same period last year, the firm posted $2.40 EPS. The company’s revenue for the quarter was up 21.7% on a year-over-year basis. Analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.